Eperezolid
CAS No. 165800-04-4
Eperezolid( PNU-100592 | PNU100592 | U-100592 )
Catalog No. M12530 CAS No. 165800-04-4
An oxazolidinone antibiotic that possesses potent antimicrobial activity in vitro and in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 258 | Get Quote |
|
10MG | 389 | Get Quote |
|
25MG | 644 | Get Quote |
|
50MG | 888 | Get Quote |
|
100MG | 1233 | Get Quote |
|
500MG | 2457 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEperezolid
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn oxazolidinone antibiotic that possesses potent antimicrobial activity in vitro and in vivo.
-
DescriptionAn oxazolidinone antibiotic that possesses potent antimicrobial activity in vitro and in vivo.Bacterial Infection Phase 3 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsPNU-100592 | PNU100592 | U-100592
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research AreaInfection
-
IndicationBacterial Infection
Chemical Information
-
CAS Number165800-04-4
-
Formula Weight394.3974
-
Molecular FormulaC18H23FN4O5
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 44 mg/mL
-
SMILESCC(NC[C@H]1CN(C2=CC=C(C3C#[N]CCN3C(CO)=O)C(F)=C2)C(O1)=O)=O
-
Chemical NameAcetamide, N-[[(5S)-3-[3-fluoro-4-[4-(2-hydroxyacetyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ford CW, et al. Antimicrob Agents Chemother. 1996 Jun;40(6):1508-13.
2. Zurenko GE, et al. Antimicrob Agents Chemother. 1996 Apr;40(4):839-45.
3. Ford CW, et al. Antimicrob Agents Chemother. 1996 Jun;40(6):1508-13.
molnova catalog
related products
-
CPFX4158
CPFX4158 is a mannose deriviative and an antibacterial agent that is potentially useful in transgenic humanized- CEACAM6 mouse.
-
Nevadensin
Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1 (hCE1) with an IC50 of 2.64 μM.
-
Chikusetsusaponin IV...
Chikusetsusaponin IVa is a novel AMPK activator, can induce insulin secretion from βTC3 cells via GPR4 mediated calcium and PKC pathways.